HOME   |    PDF   |   


Comparison of DBFS with MoCA and MMSE tools for MCI screening



Chad Chew Eun Yip*, Prem Pillay, Jasmine Kuah*, Nav Vij & Arthi Balasundaram



Neurowyzr Pte. Ltd., 6 Raffles Quay, 11-07, Singapore 048580; *Corresponding authors



Chad Chew Eun Yip - E-mail: chad@neurowyzr.com

Prem Pillay - E-mail: spinebraindoc@gmail.com

Jasmine Kuah - E-mail:  jasmine.kuah@neurowyzr.com 

Nav Vij - E-mail: nav@neurowyzr.com 

Arthi Balasundaram - E-mail: arthi.b@neurowyzr.com


Article Type

Research Article



Received May 1, 2023; Revised May 31, 2023; Accepted May 31, 2023, Published May 31, 2023



Mild cognitive impairment (MCI) has been associated with many diseases. The MCI could be a marker for the early diagnosis of certain diseases. Early detection of MCI could be beneficial for restoration of cognitive reserves. One hundred and five subjects were included in the study, underwent the Digital Brain Function Screen (DBFS) test as well as the Montreal Cognitive Assessment (MoCA) test and 73 subjects took the Mini-Mental State Examination (MMSE) test. DBFS test and retest was taken by 16 subjects. The test scores of DBFS tool showed significant positive correlation with MoCA and MMSE test scores. In conclusion, the DBFS tool could be an effective digital tool which can overcome the disadvantages of traditional tools of screening MCI like MoCA and MMSE. 



Mild cognitive impairments; MoCA; MMSE; DBFS tool; comparison



Yip et al. Bioinformation 19(5): 522-524 (2023)


Edited by

P Kangueane






Biomedical Informatics



This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.